Presentation TCT 2012 Yes: The Quantitative Threshold Should Be Lowered! Presenter: Maurice Sarano October 23, 2012
Presentation TCT 2012 TCT-96. Influence of Gender on Clinical Outcomes Following Transcatheter Aortic Valve Implantation: Results from the UK TAVI Registry on Behalf of the UK TAVI Steering Group... Presenter: Rasha Al-Lamee October 23, 2012
Presentation TCT 2012 TCT-53. Assessment of 30-day Rehospitalization for Acute Myocardial Infarction in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention: A... Presenter: Jay Bae October 23, 2012
Presentation TCT 2012 Circulatory Support for Cardiogenic Shock Presenter: E. Magnus Ohman October 23, 2012
Presentation TCT 2012 Preclinical Review: Experimental Models and Biological Considerations for the Validation of Heart Failure Devices Presenter: Juan Granada October 23, 2012
Presentation TCT 2012 TCT-54. The Influence of Smoking Status on the Pharmacodynamics of Prasugrel and Clopidogrel: The PARADOX Study Presenter: Paul Gurbel October 23, 2012
Presentation TCT 2012 Late Breaking Clinical Trials: ACRIN-PA (CTA in Low-Intermediate Risk Chest Pain) and ROMICAT II (CTA in Low-Intermediate Risk Chest Pain) Presenter: Issam Mikati October 23, 2012
Presentation TCT 2012 Radial Artery Hemostasis and Occlusion Presenter: Samir Pancholy October 23, 2012
Presentation TCT 2012 First-in-Man Results with a Myolimus-Eluting Bioabsorbable PLLA-based Vascular Scaffold (Elixir DESolve) Presenter: Stefan Verheye October 23, 2012